KeyBanc Starts NV Energy (NVE) at Hold; Positive on Yield, But Regional Economic Woes
Get Alerts NVE Hot Sheet
Price: $23.74 --0%
Rating Summary:
1 Buy, 8 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
1 Buy, 8 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
KeyBanc initiates coverage on NV Energy (NYSE: NVE) with a Hold.
Analyst, Paul T. Ridzon, said, "Resolution of NVE's Nevada Power rate case has provided an earnings uplift as the costs of the Company's Harry Allen combined cycle natural gas plant are reflected in rates that became effective January 1, 2012...The cash flow impact of the new rates has allowed a meaningful increase in
NVE's dividend, which currently offers a 3.9% yield...While we view the 7% discount as slightly excessive, we believe a lesser discount is appropriate given NVE's struggling regional economy."
For an analyst ratings summary and ratings history on NV Energy click here. For more ratings news on NV Energy click here.
Shares of NV Energy closed at $17.42 yesterday.
Analyst, Paul T. Ridzon, said, "Resolution of NVE's Nevada Power rate case has provided an earnings uplift as the costs of the Company's Harry Allen combined cycle natural gas plant are reflected in rates that became effective January 1, 2012...The cash flow impact of the new rates has allowed a meaningful increase in
NVE's dividend, which currently offers a 3.9% yield...While we view the 7% discount as slightly excessive, we believe a lesser discount is appropriate given NVE's struggling regional economy."
For an analyst ratings summary and ratings history on NV Energy click here. For more ratings news on NV Energy click here.
Shares of NV Energy closed at $17.42 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
- Vivos Therapeutics posts 35% revenue gain but widens net loss
Create E-mail Alert Related Categories
New CoverageRelated Entities
KeyBanc, Dividend, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share